Oral

[O26-4] O26-4: Pharmacogenomics (2)

Tue. Sep 26, 2017 4:00 PM - 5:00 PM Room C1 (1F)

Chairs: Tsuyoshi Fukuda, USA / Taisei Mushiroda, Japan

+Add all to schedule

[O26-4-1] Small-dosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1 and ABCG2), and interaction (atorvastatin and grapefruit Juice) profiles of five probes for OATP2B1 and BCRP

Yushi Kashihara¹, Ichiro Ieiri², Takashi Yoshikado³, Kazuya Maeda⁴, Masato Fukae⁵, Miyuki Kimura⁶, Takeshi Hirota⁷, Shunji Matsuki⁸, Shin Irie⁹, Noritomo Izumi¹⁰, Hiroyuki Kusuhara¹¹, Yuichi Sugiyama¹² (1.Kyushu University, 2.Kyushu University, 3.RIKEN Innovation Center, 4.The University of Tokyo, 5.Kyushu University, 6.Fukuoka Mirai Hospital Clinical Research Center, 7.Kyushu University, 8.Fukuoka Mirai Hospital Clinical Research Center, 9.Fukuoka Mirai Hospital Clinical Research Center, 10.Fukuoka Mirai Hospital Clinical Research Center, 11.The University of Tokyo, 12.RIKEN Innovation Center)

Cancelled

[O26-4-2] Withdrawn

[O26-4-3] Genetic polymorphisms of CYP2B6, CYP2C19, CYP2D6 and CYP3A4 genes and methadone therapy

Nurfadhlina Musa¹, Nasir Mohamad², WanNazirah Wan Yusuf³, Rusli Ismail⁴ (1.Universiti Sains Malaysia, 2.Universiti Sultan Zainal Abidin, 3.Universiti Sains Malaysia, 4.Universiti Sultan Zainal Abidin)

[O26-4-4] Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole

Chiyo K. Imamura¹, Kenichi Furihata², Ryuichi Kato³, Shinichiro Okamoto⁴, Yusuke Tanigawara⁵ (1.Keio University, 2.P-One Clinic, 3.P-One Clinic, 4.Keio University, 5.Keio University)